Azelix is a full-service CRO offering a comprehensive suite of clinical development services supporting the pharma, biotech, and medical device industries.

Azelix has an established business operation with employees globally located around the world. This allows us not only to provide you cost-effective solutions but also helps to keep projects moving throughout the day and evening using the time zone differences to our advantage. Our team consists of highly experienced professionals with the passion and expertise to make a difference in the development of new therapies.

Data-Driven Trials Management

We take a data-driven approach to clinical trials management by using historical data from past trials and deriving metrics to create the best solutions for your clinical study. Led by an executive leadership team with industry experience averaging 20+ years, Azelix has the experience and expertise to help strategically guide your clinical development.

Our Core Values

Our goal to working with our Sponsors is to be a seamless extension of your team. We strive to achieve this by always keeping our 5 core values in mind within our own organization and with yours.

  1. Respect. We value the ideas and opinions of all team members recognizing that each person brings unique experiences and expertise that will contribute to the overall success of our projects.
  2. Transparency. Be honest, open to sharing and (sometimes) criticism, and communicate. Transparency allows every individual to feel like they are a part of something bigger.
  3. Trust. Transparency helps instill trust which fosters team building and enables team members to create work that is meaningful and makes a tangible difference.
  4. Adaptability. Plans go accordingly in the perfect world but perfect isn’t always possible. We plan to mitigate risks but will adapt quickly when things don’t go as planned.
  5. Commitment. We will maintain committed to our teams and our responsibilities to ensure that our projects are executed efficiently, on time, and within budget.